HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

NCT01384734 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG: BMS-663068 400 mg
DRUG: BMS-663068 800 mg
DRUG: BMS-663068 600 mg
DRUG: BMS-663068 1200 mg
DRUG: Raltegravir 400 mg
DRUG: Tenofovir 300 mg
DRUG: Ritonavir 100 mg
DRUG: Atazanavir 300 mg

Sponsor

ViiV Healthcare